The Global Tribune

Vitiligo Market Insights, Epidemiology, and Market Forecast 2030

 Breaking News
  • No posts were found

Vitiligo Market Insights, Epidemiology, and Market Forecast 2030

March 16
10:22 2020
Vitiligo Market Insights, Epidemiology, and Market Forecast 2030
Vitiligo is a condition in which the skin loses melanin, the pigment that determines the colour of skin, hair, and eyes. If the cells that do not produce melanin die or no longer produce melanin, slowing growing white patches of irregular shapes appear on the skin. The typical lesions on the skin can be defined as milky white, non-scaly macules that are present with distinct margins.

Albany, US – DelveInsight has launched its new report on Vitiligo Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s “Vitiligo – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Vitiligo, historical and forecasted epidemiology as well as the Vitiligo market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Key facts of the report:
1. The prevalent population of Vitiligo in the 7MM was approximately 6,234,655 in 2017.
2. The U.S. accounted for the highest prevalent cases with around 2,663,753 cases in 2017.
3. Among the EU5, Germany has the highest prevalent population of Vitiligo with approximately 472,057 cases followed by the UK, which has a prevalent population of approximately 290,965 in 2017.
4. France was accounted for the lowest number of prevalent cases, among EU5 countries, with around 188,196 cases in 2017.

Report Highlights:
1. In the coming years, Vitiligo market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
2. The companies and academics are working to assess challenges and seek opportunities that could influence Vitiligo R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition       
3. Major players are involved in developing therapies for Vitiligo. Launch of emerging therapies will significantly impact the Vitiligo market
4. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Vitiligo 

Request for sample pages: https://www.delveinsight.com/sample-request/vitiligo-market

“The main symptom of Vitiligo is flat, white spots or patches on the skin. Gradually the patch will become completely white. Sometimes the centre of a patch may be white with pale skin around it.”

Many researchers have identified several forms of Vitiligo. Generalized Vitiligo (also called non-segmental Vitiligo), which is the most common form, involves loss of pigment (depigmentation) in patches of skin all over the body. Another form called segmental Vitiligo (also known as unilateral or localized Vitiligo) is associated with smaller patches of depigmented skin that appear on one side of the body in a limited area; this occurs in about 10% of affected individuals. 

The key pharma players involved in Vitiligo market are:
1. Incyte Corporation
2. Clinuvel Pharmaceutical
3. Aclaris Therapeutics
4. Celgene
5. Pfizer

The emerging drug therapies boosting the Vitiligo treatment are:
1. INCB018424
2. SCENESSE (afamelanotide)
And many others

Download a free sample report on Vitiligo @https://www.delveinsight.com/sample-request/vitiligo-market

Table of Contents:
1. Key Insights
2. Vitiligo Market Overview at a Glance
3. Vitiligo Disease Background and Overview
4. Vitiligo Epidemiology and Patient Population
5. United States Vitiligo Epidemiology
6. EU5 Epidemiology of Vitiligo
6.1. Assumptions and Rationale
6.2. Germany
6.3. France
6.4. Italy
6.5. Spain
6.6. United Kingdom
7. Japan Epidemiology of Vitiligo
8. Vitiligo Treatment Algorithm
9. Unmet Needs
10. Vitiligo Emerging Therapies
10.1. INCB018424: Incyte Corporation
10.2. SCENESSE (afamelanotide): Clinuvel Pharmaceutical
11. Other Promising Candidates
11.1. ATI?50002: Aclaris Therapeutics
11.2. Apremilast: Celgene
11.3. PF?06700841 and PF?06651600: Pfizer
12. Vitiligo: 7 Major Market Analysis
13. The United States: Market Outlook
13.1.United States Market Size
14. EU5 Countries: Market Outlook
14.1.Germany Market Size
14.2. France Market Size
14.3. Italy Market Size
14.4. Spain Market Size
14.5. The United Kingdom Market size
15. Japan: Market Outlook
15.1.Japan: Market Size
16. Market Drivers and Market Barriers
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight

Related Reports: 

Vitiligo – Epidemiology Forecast to 2030

Vitiligo Pipeline Insight, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Priya Maurya
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/